The Lived Experience of Interferon-free Treatments for Hepatitis C: A Thematic Analysis
Presentation / Conference
Whiteley, D., Whittaker, A., Elliott, L. & Cunningham-Burley, S. (2017, March)
The Lived Experience of Interferon-free Treatments for Hepatitis C: A Thematic Analysis. Poster presented at NHS Lothian R&D Conference 2017, Edinburgh
no abstract available.
Recontextualising the lived experience of hepatitis C and its treatment
Thesis
Whiteley, D. J. (2016)
Recontextualising the lived experience of hepatitis C and its treatment. (Thesis). Edinburgh Napier University. Retrieved from http://researchrepository.napier.ac.uk/Output/979740
BACKGROUND: Rapid advances in the treatment of the hepatitis C virus (HCV) have been witnessed in clinical practice over the last five years. Pharmacological developments have...
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2016)
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, 21-28. https://doi.org/10.1016/j.drugpo.2016.10.013
Background: International discourse concerning the evolution in hepatitis C virus (HCV) therapy has tended to focus on improving outcomes, shortened treatment length and reduc...
Qualitative insights into the lived experience of interferon-free treatments
Presentation / Conference
Whiteley, D. (2016, September)
Qualitative insights into the lived experience of interferon-free treatments. Paper presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
BACKGROUND: Previous research has focused on the experience of individuals undergoing interferon (IFN) based treatment for hepatitis C (HCV), however qualitative insights into...
Health-Related Quality of Life for individuals with hepatitis C: A narrative review
Journal Article
Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015)
Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936-949. https://doi.org/10.1016/j.drugpo.2015.04.019
BACKGROUND
The assessment of Health-Related Quality of Life (HRQoL) in hepatitis C (HCV) infected individuals continues to gain importance. However, rarely do reviews of this...
Why aren't we treating the treatable? An audit of all HIV/HCV co-infected individuals attending an HIV clinic
Presentation / Conference
Whiteley, D. (2011, April)
Why aren't we treating the treatable? An audit of all HIV/HCV co-infected individuals attending an HIV clinic. Poster presented at 17th Annual Conference of the British HIV Association (BHIVA
Poster abstracts.